Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.1 (
hexokinase
)
5,274
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The fluorescent dye 6-(p-toluidinyl)naphthalene-2-sulfonic acid (2,6-
TNS
) has been shown to be a sensitive and nonperturbing probe of conformational states of yeast
hexokinase
. The binding of sugar ligands to
hexokinase
induced conformational states of the enzyme which could be distinguished by monitoring 2,6-
TNS
fluorescence and correlated well with their behavior during the catalytic reaction. The binding of five-carbon sugar inhibitors such as lyxose induced a conformational state of
hexokinase
that demonstrated a small quenching of 2,6-
TNS
fluorescence but an increased ability to bind metal-ligands when compared to free enzyme. The binding of good sugar substrates such as glucose produced a conformational state of
hexokinase
which demonstrated a large enhancement (37%) of bound 2,6-
TNS
fluorescence. This glucose-induced conformational state had an increased ability to bind metal-ATP ligands; however, the relative changes in the dissociation constants for the various metal-ATP ligands differ from those observed with
hexokinase
in the presence of lyxose. Hence, the lyxose-induced conformational state of
hexokinase
was concluded to be significantly different from the glucose-induced conformational state. The binding of poor sugar substrates such as 5-thioglucose induced a conformational state of
hexokinase
similar to the conformational state induced by glucose, but with a smaller enhancement of 2,6-
TNS
fluorescence (15%) and a lesser ability to increase the affinity for metal-ATP ligands. The six-carbon inhibitor with a bulky group on the 2-position, N-acetylglucosamine, gave minimal changes in 2,6-
TNS
fluorescence and effects on metal-nucleotide binding. These conformational states are interpreted in terms of the closure of the cleft between the two domains observed by X-ray crystallography. The binding of A1ATP to free
hexokinase
was not observed at concentrations up to 100 microM, which is consistent with the kinetic properties reported for this metal-ATP ligand. Although both CrATP and A1ATP have been reported to produce a slow burst-type transient in the progress curve of
hexokinase
, only CrATP demonstrated slow changes in 2,6-
TNS
fluorescence, indicating that the conformational state of
hexokinase
induced by A1ATP is different from the conformational state induced by CrATP.
...
PMID:6-(p-toluidinyl)naphthalene-2-sulfonic acid as a fluorescent probe of yeast hexokinase: conformational states induced by sugar and nucleotide ligands. 634 55